PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 1, 2015Clinical and Translational Gastroenterology224 citationsOpen Access

The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease

View Full Paper
PPParth J. ParekhLBLuis A. BalartDJDavid A. Johnson

Key Points

Key points are not available for this paper at this time.

Abstract

There is a fine balance in the mutual relationship between the intestinal microbiota and its mammalian host. It is thought that disruptions in this fine balance contribute/account for the pathogenesis of many diseases. Recently, the significance of the relationship between gut microbiota and its mammalian host in the pathogenesis of obesity and the metabolic syndrome has been demonstrated. Emerging data has linked intestinal dysbiosis to several gastrointestinal diseases including inflammatory bowel disease, irritable bowel syndrome, nonalcoholic fatty liver disease, and gastrointestinal malignancy. This article is intended to review the role of gut microbiota maintenance/alterations of gut microbiota as a significant factor as a significant factor discriminating between health and common diseases. Based on current available data, the role of microbial manipulation in disease management remains to be further defined and a focus for further clinical investigation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Parekh et al. (2015) studied this question.

synapsesocial.com/papers/6a1fe957c1b320180d0da004https://doi.org/10.1038/ctg.2015.16
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Global burden of cancers attributable to infections in 2008: a review and synthetic analysis2012 · 2,542 citations
  2. 2Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation2011 · 1,029 citations
  3. 3Serial changes of cytokines in active ulcerative colitis: effects of antibiotic combination therapy.2009 · 17 citations
  4. 4Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen.1994 · 115 citations
  5. 5The ProbioticE. coliStrain Nissle 1917 for the Treatment of Collagenous Colitis: First Results of an Open-Label Trial2004 · 53 citations